Please join us for an afternoon of learning about the importance of and the science behind mutational testing with pathologist and GIST specialist, Dr. Christopher Corless of Portland’s Oregon Health and Science University.
This presentation will review the role of mutational analysis to subclassify GI Stromal Tumors. This can be valuable in defining prognosis and predicting responses to systemic treatments.
The webcast will include time for a Question & Answer session on topics related to the presentation.
Please note: We cannot provide individual medical advice during this Webinar. Information provided in this Webinar is not intended as a substitute for your physician’s guidance and care.
Details
Date: Thursday, August 27, 2015
Time: 12:00 PM EDT
Duration: 1 hour
Host: Sara Rothschild
Presenter Information
Christopher Corless
A member of the LRG Research Team, Dr. Corless has expertise in the application of molecular diagnostics to the classification and progonistication of solid tumors. His clinical interests include liver transplant pathology, gastrointestinal pathology and genitourinary pathology. He currently serves as a Professor of Pathology and Chief Medical Officer of OHSU’s Knight Diagnostic Laboratories.
